key: cord-0025030-7ovq72m5
authors: Chen, Yang; Wang, Wei; Zeng, Lizhong; Mi, Ke; Li, Na; Shi, Jie; Yang, Shuanying
title: Association Between Neutrophil-Lymphocyte Ratio and All-Cause Mortality and Cause-Specific Mortality in US Adults, 1999–2014
date: 2021-12-22
journal: Int J Gen Med
DOI: 10.2147/ijgm.s339378
sha: d9d2ab6fe11804ca4f637558b9b527ba2d75a382
doc_id: 25030
cord_uid: 7ovq72m5

BACKGROUND: Neutrophil-lymphocyte ratio (NLR) is a novel marker of inflammation. Emerging studies have evaluated the relationship of NLR with cardiovascular diseases and malignant conditions. However, rare studies regarded the association between NLR and long-term health status. This study aimed to evaluate the association of NLR with all-cause mortality and cause-specific mortality among adults in the United States. METHODS: We obtained eight cycles data of National Health and Nutrition Examination Surveys (NHANES) from 1999 to 2014, and enrolled 32328 participants after certain screening. By weighted chi-square test and linear regression analysis, we analyzed the correlation between NLR and baseline characteristics of the participants. Kaplan–Meier curves and Cox regression models were used to assess the survival relevance of NLR. We conducted stratified analysis, interaction analysis, and sensitivity analysis to robustness of our results. RESULTS: Participants with high NLR levels had a higher risk of death. After adjustment for baseline characteristics, the hazard ratio comparing the higher vs lower NLR levels was 1.43 (95% CI, 1.18–1.73) for all-cause mortality, 1.27 (95% CI, 0.84–1.92) for cancer mortality, and 1.44 (95% CI, 0.96–2.16) for cardiovascular disease mortality. Stratified analysis found that the observed associations between NLR levels and mortality did not differ significantly. CONCLUSION: In this nationally representative cohort of US adults, higher NLR was significantly associated with an increased risk of all-cause mortality.

Neutrophil-lymphocyte ratio (NLR) is the ratio of neutrophils to lymphocytes in the peripheral blood, which becomes a novel marker of systemic inflammation. NLR reflects the relative balance of myeloid and lymphocyte lineages, and is sensitive to the altered myelopoiesis. 1 Previous studies have shown that high NLR level associated with unfavorable clinical outcomes in a variety of diseases. Emerging studies indicated that NLR is an effective predictor of prognosis, response to therapy, recurrence in various malignancies. [2] [3] [4] [5] [6] [7] [8] [9] [10] Some studies have also shown that NLR associated with prognosis and treatment response in cardiovascular diseases. [11] [12] [13] [14] In addition, other researchers have found that NLR levels association with diagnosis and prognosis of infectious diseases such as community-acquired pneumonia, 15 bacteremia, and sepsis. [16] [17] [18] [19] [20] Elevated NLR also has been found in patients with chronic diseases including prediabetes and diabetes mellitus, 21, 22 autoimmune diseases, 23, 24 and metabolic syndrome. 25 These evidence suggest NLR as a risk factor of various diseases, but the insufficient number of participants and the short follow-up period undermine the validity of the results. Only sparse cohort studies examined the association of NLR levels with long-term health outcomes. Moreover, whether NLR is associated with risk of mortality in the general population remains unclear.

Our study aimed to examined the association of NLR levels with long-term all-cause mortality among adults in the US general population, using a large nationally representative data set from the National Health and Nutrition Examination Survey (NHANES). In addition, we evaluated the associations of NLR levels with cancer mortality and cardiovascular diseases mortality.

The NHANES collects health-related data on a nationally representative sample in the US. For each per 2-year cycles of the continuous NHANES, around 5000 participants from 15 counties in the US were selected. Data were obtained by in-home interview, physical examination, and laboratory tests. Our study used the data from the first 8 cycles of continuous NHANES, collected during the period from 1999 to 2014. The protocol of NHANES has been approved by the National Center for Health Statistics (NCHS) Ethics Review Board. Written informed consent was obtained from all participants before participation. And our study was approved by the ethics committee of School of Medicine, Xi'an Jiaotong University. The present analysis followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. 26 Participants From 1999 to 2014, 82,091 NHANES participants were linked to National Death Index. We included 42,979 participants ≥20-year-old at the baseline survey. We excluded participants who did not have physical examination (n = 2109), who lacked data of baseline blood count (n = 2184), mortality data (n = 48), and study covariates (n = 6310): smoking status (n = 37), alcohol use (n = 2835), education (n = 55), marital status (n = 464), family income-poverty ratio level (n = 2846), body mass index (n = 49), selfreported health status (n = 23). Finally, 32,328 participants were enrolled in our cohort ( Figure 1 ).

Neutrophil and lymphocyte counts were obtained from the peripheral whole blood test following established protocol and procedures. Detailed operation process of the test can be found in Laboratory Procedure Manual for NHANES. 27 The test reported neutrophil and lymphocyte counts in 1000 cells/ μL. NLR was calculated by dividing the neutrophil count by the lymphocyte count. High NLR was defined as NLR ≥ 3.

Public-Use Linked Mortality Files were provided by the NCHS. 28 We ascertained mortality status by matching the National Death Index (last followed up on 31 December 2015, updated in 2020) by the unique study identifier. Causes of deaths were determined according to the codes of international statistical classification of diseases (tenth revision). 29 In the present study, primary outcome was mortality from all causes, cancers (C00-C97), and cardiovascular diseases (codes I00-I09, I11, I13, I20-I51, and I60-I69). We defined baseline at the time subjects had physical examinations. The person-years was calculated from baseline to death, loss to follow-up or December 31, 2015, whichever occurs first.

Information on covariates was collected through baseline questionnaires, including age, sex, race/ethnicity, education level, marital status, family income poverty ratio level, drinking and smoking status, body mass index, and self-reported general health. Race/ethnicity was classified into non-Hispanic white, non-Hispanic black, Mexican American, and others. In accordance with the NCHS classifications, 30,31 the smoking status was divided into 3 categories -never smokers (who had smoked <100 cigarettes in lifetime at the time of survey), current smokers (who smoked >100 cigarettes in lifetime and still smoke), and former smokers (who had smoked >100 cigarettes but stopped smoking). Alcohol drinking was categorized as non-drinker (less than 12 alcohol drinks/lifetime), and drinker (≥12 alcohol drinks/lifetime). 30 A family's income-poverty ratio (PIR) is calculated by dividing family income by a poverty threshold. A higher PIR indicates a higher income. We categorized PIR into three groups (0-1.0, 1.1-2.9, ≥3.0). Body mass index (BMI) was calculated as individual's weight (kg) divided by the square of height (m 2 ).

Our study followed the analytic guideline by NHANES to account for the complex survey design factors, including sample weights, clustering, and stratification. Data were presented as mean± standard deviation (SD) for continuous variables and as numbers (percentages) for categorical variables. The statistical differences between groups of NLR were tested by weighted chi-square test and linear regression model for categorical variables and continuous variables, respectively. We used Kaplan-Meier analysis and Cox regression models to estimate the hazard ratios and corresponding 95% confidence intervals for associations.

We conducted stratified analyses and interaction analyses by age, gender, race/ethnicity, smoking status, BMI to evaluate whether the associations were different. In addition, we did a series of sensitivity analyses to further test the robustness of the results. Firstly, risk estimates were additionally adjusted by putting baseline history of cancer, diabetes, chronic kidney disease, cardiovascular diseases, hypertension, hyperlipemia, and chronic obstructive pulmonary diseases in the fully adjusted model. Secondly, we excluded participants with the extreme 1% of the NLR ratio to reduce the influence of underlying malignancies or other severe disease states. Thirdly, we removed participants with follow-up time of less than 35 months. Fourthly, we excluded participants with severe illnesses such as diabetes, cardiovascular disease, or cancer in order to minimize potential reverse causation.

All statistical analyses were performed on R software, version 3.6.3 (The R Foundation, Vienna, Austria). A two-sided P value <0.05 was considered statistically significant. Table 1 shows the baseline characteristics of the participants. Among the 32,328 participants, the weighted mean [SE] age at baseline was 47.4 [16.5] years; 16,484 (51.4%) were women; 16,013 (72.0%) were white. During 254,580 person-years of follow-up (median, 7.5 years; maximum, 16.8 years), 4092 deaths occurred in total, including 884 deaths from cancer and 904 deaths from cardiovascular disease. Compared with the low-NLR group, people with higher NLR were more likely to be older, men, non-Hispanic white, and have lower educational level, lower family income, lower BMI; they more likely to report baseline history of cancer, diabetes, chronic kidney disease, cardiovascular diseases, hypertension, chronic obstructive pulmonary diseases; they less likely to non-smokers, married and to report very good to excellent health status.

During 254,580 person-years of follow-up (median, 7.5 years; maximum, 16.8 years), 4092 deaths occurred in total, including 884 deaths from cancer and 904 deaths from cardiovascular disease. Kaplan-Meier curves revealed that all-cause mortality was significantly elevated among high-NLR group versus low-NLR group (Log rank test P < 0.001) ( Figure 2 ). In unadjusted Cox proportional hazards regression models, the hazard ratio (HR) of high-NLR group reached 2.20 (Non-adjusted model in Table 2 ). After adjustment for age and gender, high-NLR group still had higher risk of all-cause mortality (HR 1.53, Model 1 in Table 2 ). In the fully adjusted model including demographic characteristics, socioeconomic status, lifestyle factors, BMI, and health status, hazards of all-cause death remained elevated in high-NLR group (Model 3 in Table 2 

In the stratified analysis, the observed associations between NLR levels and mortality were not significantly different in age, gender, race/ethnicity, or BMI ( 

This study determined the association of NLR levels with all-cause and cause-specific mortality in US adults. In a cohort of US nationally representative sample, we found a robust association between all-cause mortality and NLR levels in adults. High-NLR group had a high risk of all-cause mortality. The association remained significant after taking account of demographic characteristics, lifestyle factors, socioeconomic status, and BMI. Overall, this study demonstrates that a high NLR is associated with high risk of all-cause mortality in the US general population.

Mounting evidence suggests that NLR had relation with unfavorable clinical outcomes in patients with cardiovascular diseases, malignancies, and other chronic inflammatory diseases. 4, 5, 11, 12, 23 In the general population, our results show that elevated NLR is associated with high risk of all-cause mortality. The association remains after excluding participants with cancer, diabetes or cardiovascular diseases at baseline in the sensitivity analyses (eTable 3). However, note that a higher NLR is statistically nonsignificant associated with mortality of specific causes including cardiovascular disease and cancer in our study. The reason may be that we did not have data on incident cancer, incident cardiovascular event, or site-specific cancer mortality. And we just evaluated the NLR levels with long-term outcomes in patients with cancer or cardiovascular disease. Herein, more studies are still needed to examine the associations between NLR levels and risk of cardiovascular disease and cancer.

In the presence of systemic inflammation, molecules or cellular components in the peripheral blood alter accordingly. Indicators for assessing the systemic inflammation have received increased attention and are valuable for predicting clinical outcomes in practice. [32] [33] [34] The previous studies reported that C-reactive protein may be a death prognosis factor in general people 35 and in patients with cardiovascular disease, 35,36 lung cancer, 37 or colorectal cancer. 38 Erythrocyte sedimentation rate is also a potential marker for mortality in general people 39 and in patients with nontuberculous mycobacterial pulmonary disease. 40 Other researchers reported that complete blood cell count range and albumin levels were associated with outcomes. 41 Compared with the above indicators, NLR is inexpensive, Our study has some strengths. We used the generalizability of NHANES data that contained a nationally representative sample, which enables us to generalize our findings to a broader population. Another strength of this research is that we adjusted for a variety of potential confounders, including demographic status, lifestyle factors, socioeconomic status, and BMI. Finally, our research spans a longer follow-up period (median, 7.5 years).

Our study also has limitations. Firstly, this study is limited by its observational design. Although we adjusted for many potential confounders and the cohort represents a large sample, residual confounding, especially by unmeasured variables, cannot be excluded. Secondly, we obtained the death data by acquiring the National Death Index. Due to the incomplete linkage some biases could be introduced. 42 ,43 Thirdly, whether these associations remained for hospitalized patients also warrants additional investigation. Fourthly, because this study only examined baseline NLR, and did not investigate patterns of change in NLR nor its impact on mortality, the results may have been biased in interpretation. Longitudinal studies can be further implemented to make up this limitation.

This study only analyzed the baseline NLR, and did not investigate the change pattern of NLR nor its influence in mortality, which may lead to a potential bias in the interpretation of the present results.

Our findings suggested that elevated NLR significantly associated with an increased risk of long-term all-cause mortality among US general adults. The NLR defined herein emerge from routine complete blood count testing, ensuring that it can be easily applied in clinical practice. The statistically nonsignificant associations of NLR levels with cause-specific mortality desires further investigation.

NLR, neutrophil-lymphocyte ratio; NHANES, National Health and Nutrition Examination Surveys; NCHS, National Center for Health Statistics; STROBE, strengthening the reporting of observational studies in epidemiology; PIR, income-poverty ratio; BMI, body mass index.

No additional data are available. NHANES and the NDI linkage data are publicly available at https://www.cdc.gov/ nchs/nhanes/index.htm and https://www.cdc.gov/nchs/ data-linkage/mortality-public.htm. We intend to provide relevant code on written reasonable request.

Immunomethylomics: a novel cancer risk prediction tool

Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy

Role of systemic inflammatory response markers in urothelial carcinoma

Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review

The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis

Decreased absolute lymphocyte count and increased neutrophil/lymphocyte ratio with immune checkpoint inhibitor-associated myocarditis

The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma

Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for patients with neuroendocrine tumors: an izmir oncology group study

The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: a systematic review and meta-analysis

Inflammatory markers for arterial stiffness in cardiovascular diseases

Early and late aortic propagation velocity values in STEMI patients after successful primary PCI and their relationship with neutrophil to lymphocyte ratio

Risk factors for myocardial injury in patients with coronavirus disease 2019 in China

The role of neutrophils in hypertension

Neutrophil-tolymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia

Neutrophil-to-lymphocyte ratio in patients with gram-negative sepsis admitted to intensive care unit

Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever

Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit

Neutrophil-lymphocyte ratio in predicting infective endocarditis: a case-control retrospective study

Prognostic value of neutrophil/lymphocyte ratio and mean platelet volume/platelet ratio for 1-year mortality in critically ill patients

Neutrophil: lymphocyte ratio is positively associated with subclinical diabetic cardiomyopathy

Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus

Hematological indices may be useful in the diagnosis of systemic lupus erythematosus and in determining disease activity in Behçet's disease

Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis

Neutrophillymphocyte ratio as an important assessment tool

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data

National Center for Health Statistics (NCHS)

International statistical classification of diseases and related health problems. Tenth revision

Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat 10

Cigarette smoking and health characteristics United States

Platelet-lymphocyte ratio (PLR) and all-cause mortality in general population: insights from national health and nutrition education survey

Prognostic values of LDH and CRP in cervical cancer

Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality

Associations of C-reactive protein and fibrinogen with mortality from all-causes, cardiovascular disease and cancer among U.S. adults

Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES

Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey

C-reactive protein and colorectal cancer mortality in U.S. adults

Association of blood marker of inflammation in late adolescence with premature mortality

BACES score for predicting mortality in nontuberculous mycobacterial pulmonary disease

Prognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters

Comparative analysis of the national health interview survey public-use and restricted-use linked mortality files

We thank the participants and staff of the National Health and Nutrition Examination Survey for their valuable contributions. They were not compensated for their contributions.

This study was supported by grant from the National Natural Science Foundation of China (No. 81672300). The funder had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; or the decision to submit the manuscript for publication.

All authors declare no conflicts of interest in this work.

The International Journal of General Medicine is an international, peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treatment protocols. The journal is characterized by the rapid reporting of reviews, original research and clinical studies across all disease areas. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.